Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

101.53
Delayed Data
As of Feb 27
 -2.86 / -2.74%
Today’s Change
47.03
Today|||52-Week Range
111.49
+4.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues82.8M66.7M47.2M50.6M
 
 
 
 
 
Depreciation And Amortization5.1M9.0M10.2M11.9M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses132.5M121.3M129.9M222.8M
 
 
 
 
 
Research And Development99.3M86.6M113.0M190.2M
 
 
 
 
 
Total Operating Expenses137.6M130.3M140.1M234.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-54.8M-63.6M-92.9M-184.2M
 
 
 
 
 
Extraordinary Charge-500.0K-65.9M0.00-220.8M
 
 
 
 
Pre-Tax Equity Earnings-3.5M-4.5M0.000.00
 
 
 
Other Expenses-31.0K16.4M-47.0K1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-57.6M-116.6M-91.9M-400.6M
 
 
 
 
 
Income Taxes0.00-10.6M-2.7M-40.2M
 
 
 
 
Net Income-57.6M-106.0M-89.2M-360.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.4M50.3M61.6M74.3M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M50.3M61.6M74.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.36-$2.11-$1.45-$4.85
 
 
 
 
 
EPS Diluted-$1.36-$2.11-$1.45-$4.85
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account